Correlation Between Elixinol Global and Medipharm Labs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elixinol Global and Medipharm Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elixinol Global and Medipharm Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elixinol Global and Medipharm Labs Corp, you can compare the effects of market volatilities on Elixinol Global and Medipharm Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elixinol Global with a short position of Medipharm Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elixinol Global and Medipharm Labs.

Diversification Opportunities for Elixinol Global and Medipharm Labs

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Elixinol and Medipharm is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Elixinol Global and Medipharm Labs Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medipharm Labs Corp and Elixinol Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elixinol Global are associated (or correlated) with Medipharm Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medipharm Labs Corp has no effect on the direction of Elixinol Global i.e., Elixinol Global and Medipharm Labs go up and down completely randomly.

Pair Corralation between Elixinol Global and Medipharm Labs

Assuming the 90 days horizon Elixinol Global is expected to generate 46.24 times more return on investment than Medipharm Labs. However, Elixinol Global is 46.24 times more volatile than Medipharm Labs Corp. It trades about 0.28 of its potential returns per unit of risk. Medipharm Labs Corp is currently generating about -0.04 per unit of risk. If you would invest  0.22  in Elixinol Global on September 13, 2024 and sell it today you would earn a total of  0.28  from holding Elixinol Global or generate 127.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.45%
ValuesDaily Returns

Elixinol Global  vs.  Medipharm Labs Corp

 Performance 
       Timeline  
Elixinol Global 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Elixinol Global are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, Elixinol Global reported solid returns over the last few months and may actually be approaching a breakup point.
Medipharm Labs Corp 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Medipharm Labs Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile forward indicators, Medipharm Labs may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Elixinol Global and Medipharm Labs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elixinol Global and Medipharm Labs

The main advantage of trading using opposite Elixinol Global and Medipharm Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elixinol Global position performs unexpectedly, Medipharm Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medipharm Labs will offset losses from the drop in Medipharm Labs' long position.
The idea behind Elixinol Global and Medipharm Labs Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.